Similarly, Moller et al reported that five out of seven patients with diffuse large B cell lymphomas had co-aberrations in MDM2 (amplification) and CDKN2A (deletion), when assessed by immunohistochemistry and polymerase chain reaction respectively [39]. The gene discussed is CDKN2A; the disease is diffuse large B-cell lymphoma.